BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.
Cancer Discov
; 13(11): 2448-2469, 2023 11 01.
Article
in En
| MEDLINE
| ID: mdl-37623817
Full text:
1
Database:
MEDLINE
Main subject:
Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Discov
Year:
2023
Type:
Article
Affiliation country:
France